The Effect of the U.S. Worldwide Taxation Policy on Domestic Mergers and Acquisitions

2017 ◽  
Author(s):  
Jeremiah Harris ◽  
William O'Brien
Keyword(s):  
Mergers And Acquisitions ◽  
Taxation Policy ◽  
Domestic Mergers ◽  
The U.S

scholarly journals Creditor-Focused Corporate Governance: Evidence from Mergers and Acquisitions in Japan

2011 ◽  
Vol 46 (4) ◽  
pp. 1051-1072 ◽  
Author(s):  
Vikas Mehrotra ◽  
Dimitri van Schaik ◽  
Jaap Spronk ◽  
Onno Steenbeek
Keyword(s):  
Corporate Governance ◽  
Mergers And Acquisitions ◽  
Dominant Role ◽  
Sharp Contrast ◽  
Distinctive Features ◽  
Target Firms ◽  
The World ◽  
Main Bank ◽  
The U.S

AbstractMergers in Japan have the dubious distinction of not creating wealth for shareholders of target firms, in sharp contrast to what occurs in much of the rest of the world. Using a sample of 91 mergers from 1982 through 2003 we document several distinctive features of the merger market in Japan: Mergers tend to be countercyclical and appear to be driven chiefly by creditor concerns. In particular, where the merging firms share a common main bank, we find that merger gains are lower. Overall, our results point to a market that is distinctly less shareholder focused than that in the U.S., and a market where creditors play an important, perhaps dominant, role in corporate governance.

The Costs of Mergers and Acquisitions in the U.S. Health Care Sector

1997 ◽  
Vol 27 (1) ◽  
pp. 77-87 ◽  
Author(s):  
Patrick Bond ◽  
Robert Weissman
Keyword(s):  
Health Care ◽  
Mergers And Acquisitions ◽  
Health Care Industry ◽  
The United States ◽  
Industry Concentration ◽  
Care Industry ◽  
Consumer Concerns ◽  
Pharmaceutical Industries ◽  
Pricing Power ◽  
The U.S

Important trends are emerging from evidence of health care industry concentration in the United States. Some of these are the durable consumer concerns—cost, choice, and access—which have received attention throughout the introduction of managed care. But with the intensified industry concentration, these have been joined by concerns about pricing power, control and quality, integrity of the health system and health policy-making, and clashing institutional mandates. Such trends are particularly evident in the hospital and pharmaceutical industries.

Role of Stock Markets in Stimulating Innovation Processes

2020 ◽  
Vol 64 (11) ◽  
pp. 31-41
Author(s):  
Z. Mamedyarov
Keyword(s):  
Stock Market ◽  
Mergers And Acquisitions ◽  
Stock Markets ◽  
Financial Sector ◽  
High Tech ◽  
Over The Counter ◽  
Financing Mechanism ◽  
Start Ups ◽  
The U.S

The paper deals with the role of the stock market in innovative development, basically in case of the U. S. The author shows how the NASDAQ has provided tangible financial incentives for growth of high-tech industries, emphasizes the relationship between innovation and the financial sector, the importance of competition for capital in technological development. It is shown that the development of NASDAQ and increased competition of stock markets allowed high-tech U.S. companies to benefit from country’s strong financial sector and specialized market structures. The prerequisites for the successful emergence of biotech and ICT start-ups, as well as the venture market in the U.S. are still strongly connected with stock markets. However, the comparative analysis also revealed growing global competition from the Chinese stock markets. At the same time, in the last decade a new bubble is emerging on the U.S. stock market, which, as shown by the analysis of the median revenues of the major companies, differs from similar situations before the dot-com crisis and before the 2008–2009 crisis. Revenues of the largest companies in recent years have been growing along with their capitalization, which suggests that the bubble may take much longer to collapse than before. The author also shows the intensification of competition between stock exchanges and over-the-counter financing mechanisms for innovative companies: SME acquisitions by major corporations, intensification of mergers and acquisitions around the world. The role of mergers and acquisitions, which have become an alternative to IPOs, has become increasingly important over the past decade as a financing mechanism for innovative companies. In the last decade, the ICT-companies have dominated by market capitalization and gained sufficient market power to meet the demand for new developments and acquisitions of start-ups. This over-the-counter financing mechanism increases market uncertainty and may contribute to suboptimal solutions in the high-tech sector. However, the author found that the observed decline in U.S. IPOs is primarily affecting the ICT sector, while pharmaceutical and biotech companies continue to be actively listed.

Sign in / Sign up

Export Citation Format

Share Document